PHESGO

Google image searchProduct monograph

Active ingredients

trastuzumab, 40 MG/ML

pertuzumab, 80 MG/ML

DIN: 02512912

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 08-APR-2021

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FY — Combinations of monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FY01 — PERTUZUMAB AND TRASTUZUMAB (ATC/DDD)

External Links for Phesgo

Search on Google

• Phesgo side effects
• Phesgo dosage
• trastuzumab side effects
• trastuzumab dosage
• pertuzumab side effects
• pertuzumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find phesgo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.